Cancer Vaccines: The Molecular Basis for T Cell Killing of Tumor Cells

Oncologist - United States
doi 10.1634/theoncologist.2-5-280
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody–Induced Tumor Cell Killing by Effector CD8+ T Cells

Journal of Immunology
AllergyImmunology
2019English

CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells

Cancer immunology research
Cancer ResearchImmunology
2015English

Dendritic-Tumor Fusion Cell-Based Cancer Vaccines

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2016English

Pan-BCL-2 Inhibitor AT-101 Enhances Tumor Cell Killing by EGFR Targeted T Cells

PLoS ONE
Multidisciplinary
2012English

Modulating Immunometabolism of Tumor Specific CD8 T Cells to Enhance T Cell Based Therapy for Cancer

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

The Roots of Cancer: Stem Cells and the Basis for Tumor Heterogeneity

BioEssays
BiochemistryGeneticsMolecular Biology
2012English

Molecular Basis for the Toxicity of Schweinfurthins to Breast Cancer Cells

2005English

Allogeneic Tumor Cell Vaccines

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2013English

The Molecular Basis of Lmo2-Induced T-Cell Acute Lymphoblastic Leukemia

Clinical Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy